Product
Ulipristal acetate
Aliases
Ella
Name
Ella
INN Name
ulipristal acetate
FDA Approved
Yes
4 clinical trials
4 organizations
4 indications
1 document
Indication
PregnancyIndication
UnplannedIndication
ContraceptionIndication
Breast CancerClinical trial
Levonorgestrel Intrauterine System For Emergency Contraception: a Randomized Control TrialStatus: Completed, Estimated PCD: 2018-11-30
Clinical trial
A Pilot Prospective, Randomized Pharmacodynamic Study With Assessment of Ulipristal Acetate on Ovarian Activity Following Quickstart of the Etonogestrel Contraceptive ImplantStatus: Active (not recruiting), Estimated PCD: 2022-10-10
Clinical trial
Disparities in Emergency Contraceptive Metabolism Dictate EfficacyStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
A Pilot Prevention Study of the Effects of the Anti-progestin Ulipristal Acetate (UA) on Surrogate Markers of Breast Cancer RiskStatus: Completed, Estimated PCD: 2019-03-18
Document
DailyMed Label: EllaOrganization
A-S Medication SolutionsOrganization
RPK Pharmaceuticals, Inc.Organization
HRA PHARMA AMERICA, INC.Organization
RedPharm Drug, Inc.